News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Motley Fool43d agoneutral
2 Healthcare Stocks That Just Delivered Great News for InvestorsSimply Wall St.45d agoneutral
Maze Therapeutics (MAZE) Shares Moved, So What Is Driving Attention Now?Simply Wall St.46d agoneutral
Vertex (VRTX) Stock Could Be 24% Undervalued As Kidney Trial Progress ContinuesInvestor's Business Daily47d agobullish
The Surprise That Sent Vertex - And Its Chief Rival - SoaringStocktwits47d agobullish
Twin Moves: VRTX Rises On Kidney Disease Trial Results, MAZE Rallies HarderMotley Fool52d agoneutral
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?Investor's Business Daily52d agobullish
Gene-Editing Powerhouse And Its Rivals Surge Toward A BreakoutSimply Wall St.54d agoneutral
Will Vertex’s (VRTX) New CFO Elevation and Digital Focus Reframe Its Capital Allocation Narrative?Simply Wall St.54d agoneutral
Vertex Pharmaceuticals (VRTX), Why Is It Getting Fresh Attention Now?Barrons.com54d agobullish
Why Vera Therapeutics Stock Is Jumping on New Kidney Drug Trial ResultsInvestor's Business Daily54d agoneutral
Vera Makes A Bullish Move - Times Three. Will It Hold Up To Competition?MarketBeat55d agoneutral
CRISPR Therapeutics Eyes CASGEVY Growth, Year-End Pipeline Catalysts